NCT00593411

Brief Summary

The collection of data from the myriad of services described is significantly impacted by NIH guidelines defining medical research involving humans as well as the recent implementation of HIPAA constraints which further complicate the conduct of retrospective clinical outcomes research. Simple case reports or case series analysis now involve IRB participation as well as voluminous documentation. The solution to this dilemma lies in developing and promoting secure, confidential prospective clinical databases for storing clinical data for subsequent retrospective de-identified inquiry. These databases function in a way analogous to "tissue banks" for subsequent basic science research. Patients consent to prospective entry of their clinical information into the database so long as they continue to be a patient with the Department of Neurological Surgery or the Departments or Divisions in association with the affiliated programs briefly described above. The consent is obtained during the patient's first inpatient or outpatient encounter in parallel with the HIPAA consent. It can be withdrawn by request of the patient at any time, but it does not expire unless the patient withdraws it, or the patient severs their patient care relationship with UCI Neurosurgery or the affiliated programs. The database is stored on a separate secure server maintained and backed up by the UCIMC Information Technology Department. Access to the database is restricted at multiple levels, with the majority of personnel allowed only limited access for data entry purposes. Only the database programmer/coordinator, the Department Administrator and the Chairman of the Department will have unrestricted access to the database. Authority for permission for levels of security clearance and access to the database, for other individuals, will be vested in the Chairman of the Department of Neurological Surgery. A separate IRB proposal will be formulated for individual study related to the acquisition of data from the de-identified database. Since these future studies will be performed on data sets derived from the previously consented subjects of this IRB-approved project, the requirement for additional consent forms are not anticipated. As a result IRB research proposals utilizing the database can be expedited. Once the specific study is approved, the investigator(s) are provided with the clinical information from the database in the form of a de-identified data set.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
732

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2005

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 4, 2005

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

January 3, 2008

Completed
12 days until next milestone

First Posted

Study publicly available on registry

January 15, 2008

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 9, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 9, 2012

Completed
Last Updated

March 29, 2021

Status Verified

March 1, 2021

Enrollment Period

6.9 years

First QC Date

January 3, 2008

Last Update Submit

March 24, 2021

Conditions

Keywords

MD AnalyzeCentral Nervous SystemSpine DiseasePeripheral Nerve

Eligibility Criteria

Age7 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All UCI patients with central nervous disorder, spinal disease or peripheral nerve disorder

You may qualify if:

  • Patient of one of the investigators mentioned in the IRB Protocol Narrative
  • Ability to give informed consent to have health care info collected, stored, analyzed
  • Ability to sign HIPAA form

You may not qualify if:

  • Nonpatient of one of the investigators in the study
  • Minors under the age of 7
  • Patients without the ability or capacity to give informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California, Irvine - Medical Center

Orange, California, 92686, United States

Location

MeSH Terms

Conditions

Central Nervous System DiseasesSpinal DiseasesNeuritis

Condition Hierarchy (Ancestors)

Nervous System DiseasesBone DiseasesMusculoskeletal DiseasesPeripheral Nervous System DiseasesNeuromuscular Diseases

Study Officials

  • Mark Linksey, MD

    University of California, Irvine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 3, 2008

First Posted

January 15, 2008

Study Start

August 4, 2005

Primary Completion

June 9, 2012

Study Completion

June 9, 2012

Last Updated

March 29, 2021

Record last verified: 2021-03

Locations